Anti-Tumor Effects of Metformin in Animal Models of Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis

BACKGROUND: Several studies have reported that metformin can reduce the risk of hepatocellular carcinoma (HCC) in diabetes patients. However, the direct anti-HCC effects of metformin have hardly been studied in patients, but have been extensively investigated in animal models of HCC. We therefore pe...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Juan, Hernanda, Pratika Y., Bramer, Wichor M., Peppelenbosch, Maikel P., van Luijk, Judith, Pan, Qiuwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4451077/
https://www.ncbi.nlm.nih.gov/pubmed/26030161
http://dx.doi.org/10.1371/journal.pone.0127967

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4451077/
https://www.ncbi.nlm.nih.gov/pubmed/26030161
http://dx.doi.org/10.1371/journal.pone.0127967

Ejemplares similares